ILMN - ILLUMINA, INC.

QQQ $ 602.61 $ 4.22 (0.71 %)

DIA $ 463.04 $ 0.00 (0 %)

SPY $ 665.11 $ 2.94 (0.44 %)

TLT $ 90.76 $ -0.20 (-0.22 %)

GLD $ 387.41 $ 6.60 (1.73 %)

Previous Close

$ 93

Open

$ 90.61

Bid

$ 90.60 x 10

Ask

$ 95.20 x 50

Day's Range

$ 90.10 - $ 95.61

52 Week Range

$ 68.70 - $ 156.66

Volume

2,760,045

Average Volume

Market Cap

14.29B

Beta (5Y Monthly)

$ 1.36

PE Ratio (TTM)

$ 11.37

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-01-2025	06-29-2025	10-Q
2	05-08-2025	03-30-2025	10-Q
3	02-12-2025	12-29-2024	10-K
4	11-05-2024	09-29-2024	10-Q
5	08-07-2024	06-30-2024	10-Q
6	05-03-2024	03-31-2024	10-Q
7	02-16-2024	12-31-2023	10-K
8	11-09-2023	10-01-2023	10-Q
9	08-10-2023	07-02-2023	10-Q
10	05-05-2023	04-02-2023	10-Q
11	02-17-2023	01-01-2023	10-K
12	11-04-2022	10-02-2022	10-Q
13	08-11-2022	07-03-2022	10-Q
14	05-05-2022	04-03-2022	10-Q
15	02-18-2022	01-02-2022	10-K
16	11-04-2021	10-03-2021	10-Q
17	08-05-2021	07-04-2021	10-Q
18	04-28-2021	04-04-2021	10-Q
19	02-17-2021	01-03-2021	10-K
20	10-30-2020	09-27-2020	10-Q
21	08-07-2020	06-28-2020	10-Q
22	05-01-2020	03-29-2020	10-Q
23	02-11-2020	12-29-2019	10-K
24	10-25-2019	09-29-2019	10-Q
25	07-31-2019	06-30-2019	10-Q
26	04-26-2019	03-31-2019	10-Q
27	02-12-2019	12-30-2018	10-K
28	10-24-2018	09-30-2018	10-Q
29	07-31-2018	07-01-2018	10-Q
30	04-25-2018	04-01-2018	10-Q
31	02-13-2018	12-31-2017	10-K
32	10-25-2017	10-01-2017	10-Q
33	08-03-2017	07-02-2017	10-Q
34	05-05-2017	04-02-2017	10-Q
35	02-14-2017	01-01-2017	10-K
36	11-08-2016	10-02-2016	10-Q
37	08-02-2016	07-03-2016	10-Q
38	05-09-2016	04-03-2016	10-Q
39	03-02-2016	01-03-2016	10-K
40	11-02-2015	09-27-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Illumina Releases Its Novel 5-Base Solutio...
10/15/2025 13:20:59

Illumina, Inc. (NASDAQ:ILMN) today announced the release of its novel 5-base solution, enabling researchers to pursue broader b...

cathie-wood-warns-wall-street-is-missing-ais-biggest-opportunity-in-healthcare-calling-it-sleeper-investment-poised-for-massive-returns

Cathie Wood Warns Wall Street Is Missing A...
10/15/2025 10:17:49

Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its p...

Evercore ISI Group Maintains Outperform on...
10/07/2025 17:33:33

Evercore ISI Group analyst Vijay Kumar maintains Illumina (NASDAQ:ILMN) with a Outperform and lowers the price target from $...

Assessing Illumina: Insights From 9 Financ...
10/02/2025 18:01:26

Illumina Launches New Business, BioInsight...
10/01/2025 13:08:37

New business focuses on developing data assets, software, and AI to fuel life science breakthroughsExpands pharma access to lar...

trump-administration-review-targets-medical-supply-chain-vulnerabilities

Trump Administration Review Targets Medica...
09/25/2025 18:07:16

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...

Illumina Partners With Multiple Global Pha...
09/23/2025 13:16:45

Illumina and pharma partners will develop companion diagnostics for historically important KRAS biomarkerSAN DIEGO, Sept. 23, 2...

'Element Biosciences Sues Illumina Allegin...
09/22/2025 21:25:47

https://www.genomeweb.com/sequencing/element-biosciences-sues-illumina-alleging-anticompetitive-behavior-patent-infringement

my-top-biotech-stock-picks-and-portfolio-strategy-for-the-next-3-10-years

My Top Biotech Stock Picks And Portfolio S...
09/18/2025 17:10:48

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of...

Alnylam Joins Illumina And NashBio's Allia...
09/18/2025 13:22:18

Alnylam, a leader in RNA interference (RNAi) therapeutics, will utilize the AGD dataset to inform development of 'gene sile...

Illumina Launches Protein Prep Assay Targe...
09/03/2025 13:38:55

Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel d...

icahn-hedge-funds-q2-moves-centuri-stake-soars-jetblue-held-2-positions-exited

Icahn Hedge Fund's Q2 Moves: Centuri Stake...
08/15/2025 19:07:48

Carl Icahn's 13F shows concentrated equity book, with top 10 holdings making up 98.76%. Notable changes in non-house names ...

nice-stock-stops-being-nice-has-a-bearish-breakdown

NICE Stock Stops Being Nice, Has A Bearish...
08/15/2025 14:24:24

NICE Ltd. has ended a 15-year trend with a bearish breakdown, signaling extended downside risk. Here's what the Adhishthana...

Icahn Sells Stake In Dana Inc, Illumina
08/14/2025 20:34:10

illumina-settles-with-doj-veterans-to-end-whistleblower-lawsuit

Illumina Settles With DOJ, Veterans To End...
08/06/2025 18:25:38

Illumina will pay $9.8 million to settle allegations it sold genomic systems with cybersecurity flaws to U.S. agencies. A whist...

What Does the Market Think About Illumina?
08/04/2025 16:00:48

Morgan Stanley Maintains Equal-Weight on I...
08/04/2025 14:42:19

Morgan Stanley analyst Tejas Savant maintains Illumina (NASDAQ:ILMN) with a Equal-Weight and raises the price target from $1...

cathie-woods-ark-invest-loads-up-on-coinbase-roku-illumina-and-bitmine-immersion

Cathie Wood's Ark Invest Loads Up On Coinb...
08/02/2025 10:46:06

Cathie Wood-led Ark Invest made significant trades in COIN, ROKU, ILMN, and BMNR. They also bought PD and SOFI, sold KTOS and R...

these-analysts-boost-their-forecasts-on-illumina-following-upbeat-results

These Analysts Boost Their Forecasts On Il...
08/01/2025 16:02:16

RBC Capital Maintains Outperform on Illumi...
08/01/2025 15:48:53

RBC Capital analyst Conor McNamara maintains Illumina (NASDAQ:ILMN) with a Outperform and raises the price target from $118 ...